| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | — | — |
| Cost of Revenue | $1.9M | — | — |
| Gross Profit | $185K | — | — |
| R&D Expense | $67K | — | +14.4% |
| SG&A Expense | $2K | — | -97.7% |
| Operating Income | -$326K | — | -258.3% |
| Interest Expense | $68K | — | +1887.5% |
| Income Tax | -$14K | — | — |
| Net Income | -$402K | — | -325.5% |
| EPS (Basic) | -$0.02 | — | — |
| EPS (Diluted) | -$0.02 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $408K | +74.3% | +6185.0% |
| Accounts Receivable | $2.4M | -21.6% | — |
| Inventory | $1.1M | -41.4% | — |
| Current Assets | $8.5M | -2.6% | — |
| Total Assets | $18.6M | -1.8% | — |
| Current Liabilities | $6.0M | -5.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Investing Cash Flow | -$13K | — | — |
| Financing Cash Flow | $1.2M | — | +1190.9% |
| Total Liabilities | $6.8M | -4.9% | +2968.6% |
| Stockholders' Equity | $11.8M | +0.1% | +5691.8% |